Viking Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:1VT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
31 Mar 25	Buy€27,703	Sarah Rouan	Individual	1,240	€22.34
06 Jan 25	Sell€2,069,732	Gregory Zante	Individual	50,309	€41.69
06 Jan 25	Sell€8,001,010	Brian Lian	Individual	194,490	€41.69
06 Jan 25	Sell€2,230,457	Marianne Mancini	Individual	54,215	€41.69
30 Jul 24	Sell€6,174,978	Brian Lian	Individual	115,859	€54.41
30 Jul 24	Sell€953,390	Marianne Mancini	Individual	18,026	€53.52
30 Jul 24	Sell€853,692	Gregory Zante	Individual	16,136	€54.35

Insider Trading Volume

Insider Buying: 1VT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1VT?
Owner Type	Number of Shares	Ownership Percentage
State or Government	48,630	0.0433%
Individual Insiders	2,385,516	2.12%
General Public	30,904,229	27.5%
Institutions	78,971,170	70.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 52.42% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	FMR LLC	11,248,707	€284.5m	-32.7%	0.02%
9.05%	The Vanguard Group, Inc.	10,164,257	€257.1m	-0.08%	no data
5.32%	BlackRock, Inc.	5,976,468	€151.2m	1.76%	no data
3.61%	State Street Global Advisors, Inc.	4,055,418	€102.6m	-17.7%	no data
2.57%	Morgan Stanley, Investment Banking and Brokerage Investments	2,886,020	€73.0m	19.7%	0.01%
2.46%	JP Morgan Asset Management	2,762,460	€69.9m	31.8%	0.01%
1.77%	Geode Capital Management, LLC	1,984,389	€50.2m	5.51%	no data
1.71%	Pictet Asset Management Limited	1,921,436	€48.6m	55.3%	0.04%
1.71%	Brian Lian	1,920,482	€48.6m	0.58%	no data
1.49%	Susquehanna International Group, LLP, Asset Management Arm	1,676,804	€42.4m	62.3%	0.07%
1.47%	Citadel Advisors LLC	1,651,090	€41.8m	11.2%	0.05%
1.47%	Balyasny Asset Management L.P.	1,648,628	€41.7m	91.6%	0.12%
1.28%	Braidwell LP	1,435,955	€36.3m	-2.95%	2.05%
1.26%	Columbia Management Investment Advisers, LLC	1,418,123	€35.9m	-4.15%	0.01%
1.14%	Norges Bank Investment Management	1,278,928	€32.3m	0%	no data
0.94%	UBS Asset Management AG	1,059,992	€26.8m	-1.99%	no data
0.93%	AllianceBernstein L.P.	1,039,417	€26.3m	-6.78%	0.01%
0.63%	Charles Schwab Investment Management, Inc.	711,897	€18.0m	-2.3%	no data
0.58%	Raymond James Financial Inc., Asset Management Arm	647,391	€16.4m	4.68%	0.01%
0.56%	ClearBridge Investments, LLC	631,960	€16.0m	-1.27%	0.01%
0.53%	Principal Global Investors, LLC	598,477	€15.1m	-4.87%	0.01%
0.53%	Connor, Clark & Lunn Investment Management Ltd.	597,515	€15.1m	59.2%	0.07%
0.48%	Northern Trust Global Investments	538,636	€13.6m	0.49%	no data
0.45%	Perceptive Advisors LLC	509,005	€12.9m	-48.9%	0.55%
0.45%	BNP Paribas Arbitrage Sa, Asset Management Arm	504,716	€12.8m	981%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 23:46
End of Day Share Price	2025/05/19 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Viking Therapeutics, Inc. is covered by 30 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Matthew Luchini	BMO Capital Markets Equity Research
Mayank Mamtani	B. Riley Securities, Inc.
William Frohnhoefer	BTIG